Related Experiment Video
Updated: Aug 16, 2026

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
[Bioneutralizing properties of antibodies to serotonin]
Abstract:
Experiments conducted on rabbits demonstrated formation of antiserotonin antibodies in response to introduction to the animals of a serotonin-proteinic conjugate. The effect of antibodies on the development of a serotonin- and dextran-induced inflammation in rats and on the serotonin level in cells of slices of their organs, as well as in the blood thrombocytes was studied. The antibodies were found to produce an antiphlogistic effect in regard to exogenous (serotonin-induced) and endogenous (dextran-induced inflammation) serotonin. Histochemical investigations showed the antibodies to exert a neutralizing action on intracellular serotonin.
More Related Videos
12:21Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
Related Concept Videos
Humoral Immune Responses
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Drugs Affecting Neurotransmitter Release or Uptake
Antidepressant Drugs: MAOIs and Other Agents
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists